Fosun International’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,120
Closed -$312K 222
2021
Q4
$312K Hold
1,120
0.02% 197
2021
Q3
$258K Hold
1,120
0.01% 195
2021
Q2
$257K Sell
1,120
-540
-33% -$108K 0.02% 182
2021
Q1
$308K Buy
+1,660
New +$325K 0.02% 158
2020
Q4
Sell
-1,965
Closed -$287K 203
2020
Q3
$287K Hold
1,965
0.03% 165
2020
Q2
$320K Hold
1,965
0.03% 165
2020
Q1
$272K Sell
1,965
-1,280
-39% -$176K 0.03% 153
2019
Q4
$427K Sell
3,245
-4,550
-58% -$527K 0.04% 162
2019
Q3
$876K Sell
7,795
-4,450
-36% -$495K 0.1% 115
2019
Q2
$1.36M Buy
12,245
+800
+7% +$94.2K 0.09% 134
2019
Q1
$1.48M Sell
11,445
-3,215
-22% -$391K 0.09% 126
2018
Q4
$1.66M Sell
14,660
-4,640
-24% -$518K 0.1% 99
2018
Q3
$2.06M Buy
+19,300
New +$1.93M 0.1% 84

Other funds holding LLY

Fosun International's LLY Position: Q1 2022 in Review

Fosun International sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 1,120 shares — an estimated $312K sold.

Fosun International first reported a position in LLY in Q3 2018 and held it in 13 quarters. The position peaked at $2.06M in Q3 2018. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Fosun International reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
  • Fosun International sold 1,120 Eli Lilly shares in Q1 2022, an estimated $312K.
  • Fosun International first reported a position in Eli Lilly in Q3 2018 and held it in 13 quarters.
  • Fosun International's Eli Lilly position peaked at $2.06M in Q3 2018.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Fosun International's 13F filing for Q1 2022, filed 11 May 2022.